fda approves first oral glp-1 obesity drug august 14 2025 The approved a new pill from Eli Lilly on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' Dr. LaPook has more on the new medication GLP-1 RA Adherence Shows Drop-Off

Schedule a walk with a friend Exercise doesnt have to be a chore

Instead of being swallowed and absorbed through the gastrointestinal tract (where most peptides get destroyed by digestive enzymes), the tablet dissolves on the tongue and is absorbed through the oral mucosa

Nov;271(5 Pt 1):E821-6 Am J Physiol Endocrinol Metab 2002

More than the physical changes, the mental and emotional shifts have been transformational

It is the primary organ responsible for filtering toxins from the blood

While rare, theres also a risk of developing more serious side effects, including pancreatitis, kidney damage, gallbladder disorders, or a bowel obstruction